Perspective: Rapid repurposing of drugs for COVID-19

May 08, 2020

Given the rapid spread of COVID-19 and its relatively high mortality, filling the gap for coronavirus-specific drugs is urgent. It calls for repurposing existing drugs and developing trial plans to comprehensively test these drugs for use in COVID-19 patients much more quickly than researchers, ethics boards and regulators are accosted to, say R. Kiplin Guy and colleagues in this Perspective. They highlight several existing drugs that could be repurposed for COVID-19 patients that are being tested now. The key issue with any of these potential treatments, say the authors, is to balance the needs of making treatment decisions for individual patients during epidemic peaks on the basis of clinical studies that involve small number of patients with ensuring that well-designed, randomized clinical trials are carried out rapidly. Controlled, randomized trials are needed to continue to test the efficacy and safety of drugs like hydroxychloroquine, azithromycin and remdesivir, they say. As COVID-19 is expected to be active in several seasons of disease peaks, the difficulty is to coordinate rapid studies during this first peak to justify a smaller number of well-controlled large trials to be executed in later peaks. Guy and colleagues note that researchers, ethics boards and regulators are accustomed to developing trial plans over months, not weeks--a time frame not afforded now. "It is necessary for all involved to work faster and more efficiently and then position the well-justified drugs for registrant-enabling trials during the next peak," they say.
-end-


American Association for the Advancement of Science

Related Drugs Articles from Brightsurf:

The danger of Z-drugs for dementia patients
Strong sleeping pills known as 'Z-drugs' are linked with an increased risk of falls, fractures and stroke among people with dementia, according to new research.

Wallflowers could lead to new drugs
Plant-derived chemicals called cardenolides - like digitoxin - have long been used to treat heart disease, and have shown potential as cancer therapies.

Bristol pioneers use of VR for designing new drugs
Researchers at the University of Bristol are pioneering the use of virtual reality (VR) as a tool to design the next generation of drug treatments.

Towards better anti-cancer drugs
The Bayreuth biochemist Dr. Claus-D. Kuhn and his research team have deciphered how the important human oncogene CDK8 is activated in cells of healthy individuals.

Separating drugs with MagLev
The composition of suspicious powders that may contain illicit drugs can be analyzed using a quick and simple method called magneto-Archimedes levitation (MagLev), according to a new study published in the journal Angewandte Chemie.

People are more likely to try drugs for the first time during the summer
American teenagers and adults are more likely to try illegal or recreational drugs for the first time in the summer, a new study shows.

Drugs used to enhance sexual experiences, especially in UK
Combining drugs with sex is common regardless of gender or sexual orientation, reveals new research by UCL and the Global Drug Survey into global trends of substance-linked sex.

Promising new drugs for old pathogen Mtb
UConn researchers are targeting a metabolic pathway, the dihydrofolate reductase pathway, crucial for amino acid synthesis to treat TB infections.

Can psychedelic drugs heal?
Many people think of psychedelics as relics from the hippie generation or something taken by ravers and music festival-goers, but they may one day be used to treat disorders ranging from social anxiety to depression, according to research presented at the annual convention of the American Psychological Association.

New uses for existing antiviral drugs
Broad-spectrum antiviral drugs work against a range of viral diseases, but developing them can be costly and time consuming.

Read More: Drugs News and Drugs Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.